Unither Pharmaceuticals is a global Contract Development and Manufacturing Organization (CDMO)<\/strong> specializing in sterile unit-dose, vial, and eye drop solutions<\/strong>. As a trusted pharmaceutical subcontractor<\/strong>, we support start-ups, laboratories, and large pharmaceutical companies<\/strong> from early-stage development to full-scale commercial manufacturing<\/strong>.<\/p>\n With manufacturing sites in the United States (Rochester, NY), France, and Brazil<\/strong>, we provide a complete ophthalmic portfolio, including preservative-free unit-dose and multidose vials<\/strong>.<\/p>\n Our Rochester facility is a center of excellence for unit-dose, vial, and preservative-free ophthalmic formulations<\/strong>. Following a $106 million investment in 2024<\/strong>, the site now features:<\/p>\n Our FDA-certified<\/strong> Coutances site in France specializes in the production of preservative-free multidose (PFMD) ophthalmic vials<\/strong> and BFS technology for sterile unit-dose eye drops<\/strong>. These solutions offer an alternative to traditional unit-dose formats while maintaining sterility over multiple uses<\/strong>.<\/p>\n Blow-Fill-Seal (BFS) technology is recognized as the gold standard<\/strong> for ophthalmic drug delivery, offering:<\/p>\n Unither Pharmaceuticals provides end-to-end ophthalmic manufacturing solutions<\/strong>, including:<\/p>\n At Unither Pharmaceuticals, we are committed to ensuring that our ophthalmic products align with the highest standards of patient care. As highlighted by the American Academy of Ophthalmology (AAO)<\/a>, patient-centered care is a key priority for the industry.<\/p>\n “Measuring patient-centered outcomes reflects our attempts to measure what we\u2019re already doing.” \u2013 Dr. Anne Coleman, President-Elect, AAO.<\/p><\/blockquote>\n This perspective reinforces our mission to develop and manufacture ophthalmic unit-dose, vial, and eye drop solutions that not only meet regulatory and industry standards but also prioritize patient safety, convenience, and therapeutic effectiveness<\/strong>.<\/p>\n From early-stage ophthalmic drug development<\/strong> to full-scale commercial manufacturing<\/strong>, Unither Pharmaceuticals is the subcontractor of choice<\/strong> for start-ups, biotech innovators, and global pharma leaders<\/strong>.<\/p>\nState-of-the-Art Ophthalmic Manufacturing in the United States<\/h2>\n
Unither Manufacturing LLC – Rochester, NY<\/h3>\n
\n
Coutances, France \u2013 FDA-Certified BFS Eye Drops and Multidose Vial Technology<\/h3>\n
Why BFS is the Best Choice for Ophthalmic Eye Drops & Vials<\/h2>\n
\n
Comprehensive CDMO Services for Ophthalmic Drug Development<\/h2>\n
\n
Patient-Centered Approach: Aligning with Industry Best Practices<\/h2>\n
Partner with a CDMO That Scales with Your Growth<\/h2>\n
Contact Us<\/h2>\n